Prophylactic use of immunoglobulin in bone marrow transplantation
- 1 January 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 4 (S1) , 174-180
- https://doi.org/10.1002/stem.5530040717
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- 9-(1,3-dihydroxy-2-propoxymethyl)guanine for Cytomegalovirus Infections in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1985
- Treatment of Cytomegalovirus Retinitis with 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanineAnnals of Internal Medicine, 1985
- Activity of 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the Treatment of Cytomegalovirus PneumoniaAnnals of Internal Medicine, 1985
- Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulinThe American Journal of Medicine, 1984
- Improved survival following bone marrow transplantation for aplastic anaemiaBritish Journal of Haematology, 1983
- Prevention of Cytomegalovirus Infection by Cytomegalovirus Immune Globulin After Marrow TransplantationAnnals of Internal Medicine, 1983
- Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' ExperienceClinical Infectious Diseases, 1982
- Treatment of cytomegalovirus pneumonia with high-dose acyclovirThe American Journal of Medicine, 1982
- Treatment of Cytomegalovirus Pneumonia after Marrow Transplant with Combined Vidarabine and Human Leukocyte InterferonThe Journal of Infectious Diseases, 1982
- Use of intravenous immune globulin in patients receiving bone marrow transplantsJournal of Clinical Immunology, 1982